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This process, which involves the expression of new enzymesThe pattern of expression of liver-specific and extrahe-
and changes in the concentration of those already present, ispatic S-adenosylmethionine (SAM) synthetase in devel-
known as enzymic differentiation1 and concerns a number ofoping rat liver was established by determining steady-
enzymes accounting for main liver functions,1,2 among them,state levels of the respective messenger RNAs (mRNAs)
S-adenosylmethionine (SAM) synthetase.and protein content. Levels of liver-specific SAM synthe-
SAM synthetase (EC 2.5.1.6) catalyzes the only known bio-tase mRNA increased progressively from day 20 of gesta-
synthetic route to SAM, the major donor of methyl groups,tion, increased 10-fold immediately after birth, and
from adenosine triphosphate and methionine.3 This reactionreached a peak at 10 days of age, decreasing slightly
by adulthood. Conversely, mRNA levels of extrahepatic is especially important in the liver, where as much as 48%
isoenzyme decreased toward birth, increased threefold of the methionine taken by the diet is metabolized and up to
in the newborn, and decreased further in the postnatal 85% of all transmethylation reactions occur.4,5 According to
life, reaching a minimum in the adult. Similar expres- its crucial role in this organ, mammals express a liver-specific
sion profiles were observed in isolated hepatocytes, indi- SAM synthetase isoenzyme, whereas in other tissues, the so-
cating that both mRNAs are differentially regulated in called extrahepatic or kidney-type SAM synthetase is present
the same cell type. Western blot analysis showed that (reviewed by Kotb and Geller6 and Mato et al.7). The func-
levels of immunoreactive liver-specific isoenzyme fol- tional relevance of this pattern of expression of SAM synthe-
lowed a trend similar to the mRNA, indicating that de- tase remains unclear, although some suggestions have been
velopmental regulation of this enzyme is mediated at addressed.6 These isoenzymes seem to be encoded by different
the mRNA level. Developmental patterns of expression genes, as judged by sequence comparison of the correspond-
of albumin and a-fetoprotein (AFP) mRNAs were closely ing complementary DNAs (cDNAs).8-14
related to those for liver-specific and extrahepatic isoen- Earlier studies showed that marked changes in SAM syn-
zymes, respectively. Therefore, it is suggested that liver- thetase activity occur during liver development. Thus, in
specific SAM synthetase may be a marker for hepatocyte mouse liver, Hancock15 reported a rapid increase in SAM
differentiation. Incubation of primary cultures of hepa- synthetase activity after birth from trace activities in the
tocytes from 21-day-old fetuses with permeant cyclic near-term fetus to a peak value at the age of 21 days. Fin-
adenosine monophosphate (cAMP) analogues elicited an kelstein16 also reported a significantly greater SAM synthe-
up-regulation of the mRNA for the liver-specific isoen- tase activity in the suckling and weaning rat than in the
zyme with a concomitant down-regulation of the extra- adult. In a comprehensive study, Chase et al.17 found that
hepatic message, suggesting a physiological role for the specific activity began to increase in late fetal life, reaching
increased postnatal glucagonemia in the control of this a maximum 2 days after birth and decreasing slightly byisoenzyme switching. In contrast with the isoenzyme ex- adulthood. Changes in SAM synthetase isoenzymes duringpression profiles, the levels of SAM, the product of SAM development have also been reported. Based on their respec-synthetase reaction, were determined to be greater dur- tive kinetic properties and on immunohistochemical analysis,ing gestation than in immediate postnatal periods. it has been shown that rat liver-specific SAM synthetase isThese results indicate that synthesis and utilization of expressed only in adult liver, whereas the extrahepatic isoen-SAM may be regulated differentially in fetal and adult
zyme is predominantly expressed in fetal liver and faintlyhepatocytes. (HEPATOLOGY 1996;24:876-881.)
detected in the adult organ.18,19 In humans, it has also been
reported that the extrahepatic form is weakly expressed inGrowth and development of mammalian liver proceed with
adult liver, and in contrast to the rat, the liver-specific formcharacteristic alterations of the enzyme pool through which it
is present at very low levels in fetal liver.13,14,20acquires the capability of coping with the demands of altered
environmental conditions imposed by birth and postnatal life. Altogether, the data available suggest that a SAM synthe-
tase isoenzyme switching occurs during liver development.
To date, however, a comprehensive survey of developmental
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Nembutal (Abbott Labs, North Chicago, IL). Animals were treated thetase was detected by using a rabbit antiserum raised against
purified rat liver-specific enzyme31 and goat anti-rabbit IgG horse-following the institution’s criteria for the care and use of laboratory
animals. radish peroxidase conjugate (Bio Rad, Ritchmond, CA) antibody.
Blots were developed by chemiluminiscence using DuPont New En-Isolation of Fetal, Neonatal, and Adult Hepatocytes. Fetal and neo-
natal liver hepatocytes were prepared by a nonperfusion collagenase gland Nuclear Corp. Reinassance reagents (Boston, MA).
Determination of SAM Levels. For SAM determination, liver sam-dispersion method.22 Briefly, the tissue was chopped with scissors
and incubated for 30 minutes at 377C with Ca2/-free Krebs’-bicarbon- ples of 100-200 mg were deproteinized by homogenization in 1 mL
10% trichloroacetic acid dissolved in 0.05N HCl containing 20,000ate buffer containing 0.5 mmol/L ethylene glycol-bis (b-aminoethyl
dpm of [3H-methyl]SAM at 47C. Trichloroacetic acid was eliminatedether)-N,N,N*,N*-tetraacetic acid under continuous gassing with car-
by three successive washes with diethylether saturated with 0.05Nbogen (O2/CO2; 19:1). The cell suspension was centrifuged (50g for
HCl, and samples were lyophilized. Samples were then resuspended2 minutes), and the cell pellet was resuspended and incubated for
in 100 mL of 10 mmol/L of ammonium formate, pH 4, and analyzed60 minutes in the presence of 2.5 mmol/L of Ca2/ and 0.5 mg/mL
by high-performance liquid chomatography using an Ultrasil CX col-of collagenase. At the end of the incubation period, the cells were
umn (46 1 250 mm; particle size, 10 mm) (Beckman Instruments,centrifuged and filtered through nylon membranes of 500-, 100-, and
Inc., Palo Alto, CA). After a 5-minute washing period with 0.01 mol/50-mm mesh. The contamination of hematopoietic cells of the prepa-
L of ammonium formate, pH 4.0, the elution was performed with aration was determined by microscopic observation and was 5%.
50-minute linear gradient from 0.01 mol/L to 0.8 mol/L ammoniumCell viability was always 90%. Adult hepatocytes were prepared
formate, pH 4.0, at a flow rate of 1 mL/min. The concentration offollowing the classical collagenase perfusion method.23
SAM was calculated by measuring absorbance at 254 nm. The recov-When hepatocytes were used in culture, the cell suspension was
ery was determined by measuring the amount of radioactivity pres-washed twice with sterile Dulbecco’s modified Eagle medium and
ent in a 5-mL aliquot of the sample that was injected.then resuspended in the same medium supplemented with 50 mg/
Statistical Analysis. The data shown are the means { SEM ofmL of penicillin G and 50 mg/mL of streptomycin. Fetal hepatocytes
three to four experiments, each one performed with four to eight(3-4 1 106) were plated in 6-cm tissue-culture dishes in 2.5 mL of
animals. Statistical significance was estimated with Student’s t testDulbecco’s modified Eagle medium supplemented with 10% fetal calf
for unpaired observations. A P value.05 was considered significant.serum. After 4 hours of incubation to facilitate cell attachment to
In studies of RNA (Northern blot) or protein (Western blot) determi-the plate, the medium was aspirated, the plates were washed twice
nation, linear correlation between increasing amounts of input RNAwith phosphate-buffered saline to remove the nonadherent cells and
or protein and signal intensity were observed (correlation coefficientfilled with 2 mL of Dulbecco’s modified Eagle medium, containing 10
of 0.9).mg/mL of fatty acid–free bovine serum albumin. Hormone additions
were made so that the changes in the total incubation volume were
2%. Dexamethasone and insulin were added to a final concentra- RESULTS
tion of 1 mmol/L; prolactin was added at 100 nmol/L, and ph–cyclic
adenosine monophosphate (cAMP) plus theophylline were added at The pattern of expression of both liver-specific and extrahe-
100 mmol/L. Hormones and other agents were obtained from Novo patic SAM synthetase in developing rat liver was determined
Industri A/S (Copenhagen, Denmark), Sigma Chemical Co. (St. by Northern blot, using specific cDNA probes. As previously
Louis, MO), and Merk AG (Darmstadt, Germany). reported,9,10 the liver-specific cDNA probe failed to cross-hy-
cDNA Probes. A cDNA comprising 1,147 base pairs of the rat extra- bridize with the mRNA for the extrahepatic isoenzyme and
hepatic SAM synthetase was obtained by reverse-transcription cou- vice versa.pled to polymerase chain reaction. Primers were designed according
As shown in Fig. 1, the content of liver-specific SAM syn-to the published cDNA sequence.10 The first cDNA strand was syn-
thetase mRNA detected in pooled livers derived from animalsthesized from 3 mg of rat kidney Poly (A)/ (Clontech, Palo Alto, CA)
of 20-22 days of gestation is rather low, although it increasesRNA using 200 U of Moloney murine leukemia virus reverse-tran-
progressively until birth. Immediately after birth, the rate ofscriptase (Superscript II; GIBCO BRL, Paisley, Scotland) and the
downstream primer (5*-AGCTGTCCCTACCAAAGTGGC-3* ), com- increase rises sharply, resulting in an approximately 10-fold
plementary to nucleotide residues 1133-1153 of the extrahepatic change in the mRNA levels. These levels then remain con-
SAM synthetase sequence. The cDNA was then subjected to polymer- stant at least until 10 days of age but decrease slightly by
ase chain reaction amplification with the above primer and the up- adulthood. The expression profile shown by the extrahepatic
stream primer (5*-CGGGCAGCTCAACGGCTTCCA-3* ), correspond- SAM synthetase mRNA falls into a markedly different pat-
ing to nucleotides 6-26. Amplification was performed as described tern. The highest levels are detected at day 20 of gestationpreviously24 but using the thermostable DNA polymerase Dynazyme
and decrease toward birth, increasing threefold in the new-(Finnzymes, Oy, Finland). The resulting fragment was purified, in-
born. Subsequently, a rapid reduction in the mRNA contentserted into the SmaI site of pUC18 plasmid, and sequenced by the
is observed 3 hours after birth, returning to the value mea-dideoxy chain termination method25 to confirm its authenticity.
sured the last day of gestation. Then, it remains essentiallyOther cDNA fragments used as probes were as follows: a 2.2-kilobase
EcoRI fragment of the rat liver-specific SAM synthetase cDNA constant throughout the first 20 days of postnatal life, reach-
SSRL9; a fragment comprising 1.1 kilobases of rat albumin cDNA ing the lowest concentration in the adult rat. These results
clone pRSA1326; a 0.6-kilobase fragment of the cDNA for rat a-feto- were reproduced without significant variations in four inde-
protein (AFP)27; and a cDNA for the 18S ribosomal RNA inserted pendent experiments. It is worth noting that blots hybridized
into plasmid pBR322 was used for normalization. with the extrahepatic SAM synthetase probe were subjected
Northern Blot Analysis. Total RNA was isolated by the guanidi- to an exposure 10 times longer than when hybridized withnium isothiocyanate method.28 Aliquots of RNA (30 mg) were size
the liver-specific SAM synthetase probe, although the specificfractionated on a 0.9% agarose denaturing gel and transferred to
activity of both probes was similar. It is therefore concludedNytran membranes (Schleicher and Schuell, Keene, NH). Prehybrid-
that, in general, outstanding differences exist in net expres-ization and hybridization were performed as described previously.29
sion of both mRNAs, and these differences enlarge through-The probes were random primed labeled with [a-32P]deoxycytidine
triphosphate using the Readyprime labeling kit (Amersham Ltd., out development, as judged by the intensity ratio of the corre-
Little Chalfont, England). The filters were scanned on a Molecular sponding signals (Fig. 1B).
Imager GS-250 (Bio-Rad Laboratories, Richmond, CA), and quantita- Albumin and AFP levels were also determined as a control
tive analysis was performed running the Phosphor analyst software for the assessment of the developmental status of the tissue.
(Bio-Rad Laboratories). The expression of both mRNAs followed the expected pat-
Western Blot Analysis. Samples from rat liver or hepatocytes were tern.32,33 Thus, albumin mRNA content increased in late fetalhomogenized in 10 mmol/L Tris-HCl, pH 7.5, and 0.3 mol/L sucrose
life and persisted to adulthood at comparable levels. Thebuffer. Twenty micrograms of proteins from the cytosolic fractions
amount of AFP also increased throughout the late fetal periodwere loaded onto 10% sodium dodecyl sulfate–polyacrylamide gel
but decreased after birth and became undetectable at day 20electrophoresis gels and electrophoresed as described previously.30
of postnatal life. It is interesting to note that liver-specificProteins were electrotransferred to nitrocellulose membranes using
20 mmol/L of Tris-HCl, pH 7.5, containing 20% methanol. SAM syn- SAM synthetase could be a reliable indicator of the differenti-
AID Hepa 0015 / 5p14$$$282 09-10-96 17:19:48 hpta WBS: Hepatology
878 GIL ET AL. HEPATOLOGY October 1996
rats closely resembles that found in the total liver, except for
AFP, whose levels appear to be relatively greater 3 days be-
fore birth. The intensity ratio of the signals yielded by liver-
specific and extrahepatic SAM synthetase mRNA bands in
hepatocytes (Fig. 2B) is also similar to that observed in the
total liver. Therefore, it is concluded that changes in the de-
velopmental program of both mRNAs occur in the same cell
type.
To further define the molecular basis for the regulation
of liver-specific SAM synthetase in different developmental
stages, we also determined the content of the specific protein.
Extracts of cytosolic proteins derived from aliquots of the
same samples used for Northern analysis were subjected to
immunoblotting. As shown in Fig. 3, changes in the specific
protein during development show a trend similar to the corre-
FIG. 1. Developmental regulation of liver-specific and extrahepatic SAM
synthetase mRNAs in rat liver. (A) Northern blot of total RNA (30 mg) derived
from rat livers at the indicated stages of development. For fetal and newborn
stages, livers were pooled from several individuals. (A) Signal obtained after
hybridization of the membrane with [32P]cDNA probe for liver-specific SAM
synthetase. A longer exposure of the lanes corresponding to fetal stages is
shown below. The same blot was hybridized subsequently to extrahepatic SAM
synthetase, albumin, and AFP probes. The exposure period of the blot after
hybridization with the extrahepatic SAM synthetase probe was 10 times longer
than for the corresponding liver-specific SAM synthetase probe. (B) The inten-
sity ratio of liver-specific SAM synthetase/extrahepatic SAM synthetase (j)
and liver-specific SAM synthetase/albumin (h) mRNA bands obtained by den-
sitometric scanning of the blots and normalized against 18S ribosomal RNA.
Values are expressed as the percentage relative to the point that yielded the
highest ratio. Statistical significance is as follows: P  .001, prenatal days vs.
postnatal period. The figure reflects a typical result representative of four
independent experiments.
ated state of the hepatocyte, as deduced by the liver-specific
SAM synthetase/albumin ratio shown (Fig. 1B).
It is well known that fetal liver contains a high population
of hematopoietic cells among hepatocytes, and a sharp de-
crease in its quantity as birth approaches can contribute to
developmental changes in enzyme and isoenzyme contents.34
This factor could be influencing the results derived from fetal
samples, especially those concerning the expression of the
mRNA for the extrahepatic isoenzyme. Therefore, we next
examined whether the mRNA expression profiles found in
FIG. 2. (A) Northern blot prepared from equal amounts (30 mg) of total RNAthe total liver also takes place in isolated hepatocytes. Albu-
from isolated rat hepatocytes at different developmental stages was hybridizedmin and AFP mRNA content were also measured as markers
sequentially with the indicated probes. The time of exposure of the blots wasfor hepatocyte lineage. As shown in Fig. 2, the expression as detailed in Fig. 1. (B) Intensity ratio of liver-specific SAM synthetase/extra-
profiles of the four mRNA species analyzed in hepatocytes hepatic SAM synthetase mRNA bands. Results shown are representative of
four experiments.from fetuses of 20- to 22-day gestation, newborn, and adult
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4, when fetal hepatocytes were incubated with a permeant
analogue of cAMP, an important up-regulation of the liver-
specific SAM synthetase concomitant with a down-regulation
of the extrahepatic isoenzyme was observed. When hepato-
cytes were incubated with insulin, even at concentrations
that involve the occupation of the insulin or insulin-like
growth factor receptor dexamethasone or prolactin, the be-
havior of the two messages was the same as in untreated
cells. It is of interest to mention that on culture, fetal hepato-
cytes showed a progressive loss of the mRNA levels for the
liver-specific enzyme, which again argues in the sense of an
increased expression of this specific isoenzyme as hepatocyte
maturation and differentiation develops.
Altogether, the results described above are consistent with
the developmental patterns of SAM synthetase activity de-
scribed previously.15,17 To determine whether these changes
also correlate with SAM content, the levels of this metabolite
at different developmental stages were measured (Fig. 5).
Unexpectedly, the concentration of hepatic SAM in fetuses
and newborns is significantly greater than that measured in
the immediate postnatal periods (P  .05) and similar to the
one detected in adult rat.
DISCUSSION
In the present study, we have delineated the develop-
mental patterns of expression of liver-specific and extrahe-
patic SAM synthetases by determining the respective mRNA
levels. This approach was followed as an accurate way to
discriminate both isoenzymes, bearing also in mind that
changes in the production of proteins during normal develop-
ment are controlled primarily at the level of mRNA synthe-
sis.37,38
Our results show that a switch in the predominant expres-
sion from the extrahepatic to the liver-specific isoenzyme oc-
curs in rat liver in late fetal life. The concentration of the
mRNA for the liver-specific SAM synthetase increases from
the earliest fetal age studied, increases strikingly after birth,
and peaks at age 10 days. Conversely, mRNA levels of the
extrahepatic isoenzyme decrease gradually until birth and
reach a minimum in the adult life. Interestingly, isolated
hepatocytes mimic isoform switching, indicating that both
mRNAs are differentially regulated in the same cell type.FIG. 3. Developmental regulation of immunoreactive liver-specific SAM
This finding also excludes the possibility that changes ob-synthetase. Equal amounts of cytosolic proteins (20 mg) derived from (A) rat
liver or (B) rat hepatocytes at the indicated developmental stages were frac- served in the content of extrahepatic mRNA in total liver
tionated by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis could be caused by the contribution of hematopoietic cells
and subjected to immunoblot analysis with an antibody raised against the
present in different proportions at each fetal stage.liver-specific SAM synthetase (dilution 1:10,000). (C) To test the specificity of
Results concerning the presence of liver-specific SAM syn-the antibody, cytosolic proteins from rat kidney and spleen were also subjected
to Western analysis. (D) Densitometric analysis of immunoreactive liver-spe- thetase mRNA in fetal rat liver differ from previous studies
cific SAM synthetase at different developmental stages in total liver (j) and that suggested a lack of expression of this isoenzyme at this
isolated hepatocytes (
 
 ). Statistical significance is as follows: P  .001, prena-
developmental stage.18,19 This discrepancy may be caused bytal days vs. postnatal period. The figure shows a representative experiment of
the different methods used to detect the respective isoen-four experiments.
zymes. Another possibility would be that formation of the
mRNA does not necessarily determine the time of appearance
of the corresponding protein. Indeed, this is the case withsponding mRNA expression either in total liver or in hepato-
cytes. The antibody raised against the liver-specific SAM syn- albumin and AFP, which are detected 1 day later than their
respective mRNAs.39 However, Western blot analysis per-thetase did not cross-react with the extrahepatic form
because no signal was detected either in kidney or spleen formed with a specific antibody that does not recognize the
extrahepatic isoenzyme showed that liver-specific SAM syn-(Fig. 3C), two tissues where only this isoenzyme is expressed.
The marked accumulation of liver-specific SAM synthetase thetase is present at the same time that the mRNA is de-
tected in both total liver and hepatocytes. Furthermore, theobserved immediately after birth suggests that the hormonal
changes characteristic of neonatal animals could be the fac- levels of the protein change during liver development in a
manner similar to the corresponding mRNA.tors responsible for this cut-off switch. An important gluca-
gonemia associated with a decrease in the insulin levels has Overall, there is a good correlation between the results
presented here and the developmental profiles of activity re-been considered one of the factors that trigger the regulation
of gluconeogenic enzymes.35 In addition to these hormones, ported previously,15,17 suggesting a regulatory mechanism
acting primarily at the mRNA level. The involvement of otherprolactin reaches a peak in the newborn.36 Therefore, we de-
cided to investigate whether by using an ex vivo system of mechanisms modulating the activity of either isoenzyme at
different stages of development cannot be ruled out but, ascultured fetal hepatocytes (21 days of gestation) these hor-
mones could reproduce the expression patterns of SAM syn- deduced from the studies by Chase et al.,17 it seems unlikely.
Therefore, as judged by the resulting expression patterns, itthetase isoenzymes observed after birth. As shown in Fig.
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FIG. 4. Effect of hormones on
liver-specific and extrahepatic SAM
synthetase mRNAs in primary cul-
tures of fetal hepatocytes. Hepato-
cytes from 21-day-old fetuses were
cultured as detailed in Materials and
Methods and were incubated for 3, 6,
and 18 hours in the absence or pres-
ence of the indicated effectors. (A)
Northern blot analysis performed
with 30 mg of total RNA. Filters were
hybridized sequentially with liver-
specific and extrahepatic SAM syn-
thetase probes. The time of exposure
was as indicated in Fig. 1. (B) Inten-
sity ratio of liver-specific SAM
synthetase/extrahepatic SAM syn-
thetase mRNA bands after normal-
ization against 18S ribosomal RNA.
Results are expressed relative to the
value at time zero, which was taken
as 100%. The figure reflects a repre-
sentative experiment of three experi-
ments. (s), Control; (L), dexametha-
sone; (n), prolactin; (m), insulin; (j)
ph-cAMP.
is conceivable to speculate that, in late gestation, the SAM SAM synthetase is caused by the modulation of gene tran-
scription and/or stability of the mRNA is not known. Mostsynthetase activity reported must be attributed to a mixed
action of both isoenzymes. The rapid increase in the activity of the liver-specific gene products found to be dramatically
induced at birth are regulated at the transcriptional level.40,41detected after birth can be mainly associated with the sharp
increase in the expression of the liver-specific form. Measure- This regulation is commonly dependent on glucocorticoids
and hormones that elevate the intracellular level ofments of activity in the postnatal life also would be attributed
essentially to the action of this isoenzyme because the expres- cAMP.35,38 The mechanism that controls the switch of SAM
synthetase isoenzymes also appears to be related to the im-sion of extrahepatic SAM synthetase decreases after birth
and seems to be almost residual in the adult life. portant hormonal changes that occur during perinatal transi-
tion. The ability of cAMP to evoke SAM synthetase isoenzymeWhether the mRNA expression pattern of the liver-specific
switching in primary cultures of fetal hepatocytes suggests
that glucagon is the hormonal stimulus that triggers this
regulation. In fact, the insulin/glucagon ratio decreases
markedly in response to the well-known postnatal hypoglyce-
mia, resulting in a concomitant increase in the concentration
of intracellular hepatic cAMP.42 The physiological relevance
of these metabolic changes has been widely shown, being
involved in the formation of many hepatic enzymes that accu-
mulate precipitously after birth, such as those involved in
the control of carbohydrate metabolism.35
An interesting finding is that liver-specific SAM synthetase
expression parallels the switch on of the albumin gene, show-
ing a notorious increase around delivery that remains stable
up until the adult life. Also, changes in development in AFP
and liver-specific SAM synthetase mRNAs either in total
liver or in hepatocytes occur in opposite directions. These
results suggest that liver-specific SAM synthetase could be
a trait of the differentiated state of the hepatocyte. Related
to this, it is worth noting that hepatocyte culturing is accom-
panied by a loss of the liver-specific isoenzyme mRNA, an
effect readily attributed to the classic phenomenon of dedif-
ferentiation of primary cultures. It also should be mentioned
that, in a dedifferentiated hepatic cell line such as rat hepa-
toma H35, the levels of the liver-specific SAM synthetase are
comparatively much lower than in hepatocytes (Gil B, et al.,
Unpublished observation, October, 1995).
The necessity of modulating SAM synthetase expression
as a function of development must be oriented to cope with
the changing demands of SAM. In this context, intriguing
questions derive from the finding that, in contrast to the
overall SAM synthetase expression pattern, levels of SAM
FIG. 5. Hepatic concentration of SAM in rats at different stages of de- are significantly greater in late gestation and after birth thanvelopment. Results are shown as mean { SEM of four different preparations.
in immediate postnatal periods. This may be interpreted inValues from fetuses, newborns, and adults were significantly different than
those measured in the immediate postnatal group (P  .05). the light of previous studies performed in humans43 and
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18. Okada G, Watanabe Y, Tsukada K. Changes in patterns of S-adenosyl-rats,44 which showed that marked alterations in hepatic SAM
methionine synthetases in fetal and postnatal rat liver. Cancer Res 1980;synthetase do not necessarily result in significant changes in 40:2895-2897.
SAM levels, a finding that was considered as indicative that 19. Horikawa S, Ozasa H, Ota K, Tsukada K. Immunohistochemistry analysis
of rat S-adenosylmethionine synthetase isozymes in developmental liver.the rate of utilization of this metabolite is accommodated to
FEBS Lett 1993;330:307-311.the rate of its synthesis.43 Another possible explanation is
20. Liau MC, Chang CF, Belanger L, Grenier A. Correlation of isoenzymerelated to a putative maternal supply of SAM. Consequently, patterns of S-adenosylmethionine synthetase with fetal stages and patho-
with this hypothesis, the sharp increase in expression of liver- logical states of the liver. Cancer Res 1979;39:162-169.
21. Di Marco PN, Ghisalberti AV, Pearce PH, Oliver IT. Postnatal changes inspecific SAM synthetase immediately after birth may be pro-
blood glucose, phosphopyruvate carboxylase and tyrosine aminotransfer-duced in response to the loss of the maternal source.
ase after normal birth and premature delivery in the rat. Biol NeonateIt can be finally concluded that SAM synthetase activity 1976;30:205-215.
present in fetal hepatocytes is sufficient to cope with the 22. MartıB n-Sanz P, Cascales M, Bosca´ L. Fructose 2,6-biphosphate in isolated
foetal hepatocytes. FEBS Lett 1987;225:37-42.supply of SAM to the cell, a situation that, apparently, does
23. MartıB n-Sanz P, Cascales M, Bosca´ L. Glucagon-induced in fructose 2,6-not apply to the postnatal hepatocyte. Unraveling of the mo-
biphosphate and 6-phosphofructo-2-kinase in cultured rat foetal hepato-lecular basis for the necessary commitment of the expression cytes. Biochem J 1989;257:795-779.
of a liver-specific SAM synthetase can contribute to a better 24. Alvarez L, Mingorance J, Pajares MA, Mato JM. Expression of rat liver
S-adenosylmethionine synthetase in Escherichia coli results in two activeunderstanding of mammalian liver physiology.
oligomeric forms. Biochem J 1994;301:557-561.
25. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminatingAcknowledgment: The authors thank Drs. J. L. Danan
inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-5467.and I. Fabregat for the generous gift of albumin and AFP;
26. Sargent TD, Wu JR, Sala-Trepat JM, Wallace RB, Reyes AA, Bommer J.
and Drs. E. Alonso-Aperte, J. Mingorance, and G. Varela- The rat albumin serum gene: analysis of cloned sequences. Proc Natl Acad
Moreiras for the critical reading of the manuscript. Sci U S A 1979;76:3256-3260.
27. Jagodzinski LL, Sargent TD, Yang M, Glackin C, Bommer J. Sequence
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